Alhaddad J, Allos H, Dimitrov D, Nader C, Rennke H, Jaber B
Clin Nephrol Case Stud. 2025; 13():1-7.
PMID: 39816676
PMC: 11730055.
DOI: 10.5414/CNCS111506.
Cozzo D, Orlando F, Bruno M, Ogna A, Ogna V
J Nephrol. 2024; .
PMID: 39352607
DOI: 10.1007/s40620-024-02084-6.
Forster A, Sabur N, Iqbal A, Vaughan S, Thomson B
BMC Nephrol. 2024; 25(1):285.
PMID: 39217294
PMC: 11366146.
DOI: 10.1186/s12882-024-03716-6.
Lee S, Jung S, Jeon H, Jang H, Kim H, Lee T
Biomed Hub. 2024; 9(1):62-66.
PMID: 38638677
PMC: 11026070.
DOI: 10.1159/000538279.
Muhammad A, Zhang Y, Huang L, Yuan Q, Wang W, Pu J
Clin Kidney J. 2024; 17(4):sfae054.
PMID: 38572500
PMC: 10986214.
DOI: 10.1093/ckj/sfae054.
Minimal change disease following COVID-19 vaccination: A systematic review.
Kechagias K, Laleye J, Drmota J, Geropoulos G, Kyrtsonis G, Zafeiri M
PLoS One. 2024; 19(3):e0297568.
PMID: 38442131
PMC: 10914286.
DOI: 10.1371/journal.pone.0297568.
[Diagnosis and treatment of Minimal Change Disease in adults-2023].
Gauckler P, Regele H, Eller K, Saemann M, Lhotta K, Zitt E
Wien Klin Wochenschr. 2023; 135(Suppl 5):628-637.
PMID: 37728648
PMC: 10511370.
DOI: 10.1007/s00508-023-02258-5.
Prostate Cancer Associated with Minimal Change Disease: A Case Report.
Nakano Y, Yoshida M, Muraki N, Sugita K, Ishihara S, Kumagai J
Glomerular Dis. 2023; 2(3):145-150.
PMID: 36751666
PMC: 9710312.
DOI: 10.1159/000525040.
Spontaneous remission of idiopathic minimal change disease in a cat.
Broadbridge C, Hall H, McCallum K
JFMS Open Rep. 2022; 8(2):20551169221131261.
PMID: 36389213
PMC: 9643767.
DOI: 10.1177/20551169221131261.
Defining diagnostic trajectories in patients with podocytopathies.
Cirillo L, Lugli G, Raglianti V, Ravaglia F, Buti E, Landini S
Clin Kidney J. 2022; 15(11):2006-2019.
PMID: 36325008
PMC: 9613436.
DOI: 10.1093/ckj/sfac123.
Mycophenolate mofetil and telmisartan for the treatment of proteinuria secondary to minimal change disease podocytopathy in a dog.
Travail V, Cianciolo R, Peak K, Di Bella A
J Vet Intern Med. 2022; 36(6):2187-2190.
PMID: 36151875
PMC: 9708429.
DOI: 10.1111/jvim.16534.
Cytomegalovirus-Associated Nephrotic Syndrome in a Patient with Myasthenia Gravis Treated with Azathioprine: A Case Report.
Xu Y, Chen M, Xie L, Zhang X, Wang Y, Gu X
Am J Case Rep. 2021; 22:e933380.
PMID: 34582431
PMC: 8488190.
DOI: 10.12659/AJCR.933380.
Ibuprofen-associated minimal change disease and acute interstitial nephritis with possibly linked membranous glomerulonephritis.
Liu A, Chang Y, Zuckerman J, Kalantar-Zadeh K, Ghobry L, Hanna R
SAGE Open Med Case Rep. 2021; 9:2050313X211025145.
PMID: 34221404
PMC: 8221701.
DOI: 10.1177/2050313X211025145.
Rifampicin-Associated Secondary Minimal Change Disease Presenting with Nephrotic Syndrome in a Pulmonary Tuberculosis Patient.
Sathi S, Garg A, Singh M, Saini V, Vohra D
Case Rep Nephrol. 2021; 2021:5546942.
PMID: 33936823
PMC: 8060098.
DOI: 10.1155/2021/5546942.
CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease.
Teh Y, Lim S, Jusoh N, Osman K, Mualif S
Biomed Res Int. 2021; 2021:6671552.
PMID: 33506028
PMC: 7806396.
DOI: 10.1155/2021/6671552.
Minimal change disease concurrent with acute interstitial nephritis after long-term use of sorafenib in a patient with renal cell carcinoma.
Ihara K, Rai T, Nishida H, Sasaki S, Uchida S
CEN Case Rep. 2021; 10(2):287-293.
PMID: 33389633
PMC: 8019407.
DOI: 10.1007/s13730-020-00558-7.
Secondary Minimal Change Disease Due to Pancreatic Cancer Improved by Chemotherapy.
Masuda S, Koizumi K, Moriya H, Nishino T, Uojima H, Tazawa T
Intern Med. 2020; 60(2):251-257.
PMID: 32963158
PMC: 7872799.
DOI: 10.2169/internalmedicine.5499-20.
The revised version 2018 of the nationwide web-based registry system for kidney diseases in Japan: Japan Renal Biopsy Registry and Japan Kidney Disease Registry.
Ozeki T, Maruyama S, Nagata M, Shimizu A, Sugiyama H, Sato H
Clin Exp Nephrol. 2020; 24(11):1058-1068.
PMID: 32761468
PMC: 7524691.
DOI: 10.1007/s10157-020-01932-6.
Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis.
Shima H, Okamoto T, Tashiro M, Inoue T, Masaki C, Tada H
Kidney Med. 2020; 1(2):75-78.
PMID: 32734188
PMC: 7380391.
DOI: 10.1016/j.xkme.2019.03.001.
Ovarian tumor and glomerulopathies: case report and review of the literature.
Benabdellah N, Izzedine H, Bentata Y, Haddiya I
Pan Afr Med J. 2019; 34:75.
PMID: 31819791
PMC: 6884736.
DOI: 10.11604/pamj.2019.34.75.6008.